Tetramethylpyrazine ameliorates hepatic fibrosis through autophagy-mediated inflammation.

CONCLUSIONS: TMP exerts therapeutic effects in hepatic fibrosis mainly through promoting autophagy to ameliorate inflammation by inhibiting the AKT-mTOR signalling pathway, providing a new perspective for the treatment of chronic liver diseases. PMID: 32383631 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32383631?dopt=Abstract

Source: Biochemistry and Cell Biology - May 7, 2020 Category: Biochemistry Authors: Hu Z, Su H, Zeng Y, Lin C, Guo Z, Zhong F, Jiang K, Yuan G, He S Tags: Biochem Cell Biol Source Type: research